Journal of Korean Medical Science · 2021 · 20 citations · 20 references
MedicineEndocrinologyInternal MedicineClinical EpidemiologyDisease SurveillanceHealth InsuranceChronic DiseaseComorbidityComorbidity AssessmentDiabetes MellitusAnnual IncidenceClinical PrevalenceHazard Ratio ModelingIncidence RateIncidence Rate RatioSurvival Rate Estimation
BACKGROUND: Acromegaly is a rare, slowly progressive disease. Its mechanism is not fully understood, and epidemiological research on Korean patients with acromegaly is scarce. The purpose of this study was to determine the incidence and prevalence of acromegaly and assess the comorbidities and survival benefits based on treatment options. METHODS: This nationwide population-based cohort study was conducted using data of the Korean Health Insurance Review and Assessment claims database to evaluate the incidence of newly diagnosed acromegaly cases during 2013-2017. RESULTS: < 0.001). CONCLUSION: The annual incidence rate of Korean patients with acromegaly was similar to that reported in previous studies. Using nationwide population data, our study emphasized the importance of treatment in acromegaly patients.
20
Mônica R. Gadelha, Marcello D. Bronstein, Thierry Brue et al. · The Lancet Diabetes & Endocrinology · 2014 · 402 citations
Mathias Z. Strowski, Rupa M. Parmar, Allan D. Blake et al. · Endocrinology · 2000 · 348 citations · Full text